1st Covid Vaccine For Children Above 12 Approved In India, featuring PharmaJet
India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country. Read More →
Scancell Holdings PLC to use needle-free technology for next-generation vaccine candidates, featuring PharmaJet
Scancell Holdings PLC (AIM:SCLP, FRA:SCP) (AIM:SCLP) said it will use PharmaJet’s needle-free technology to administer Covid vaccine candidates SCOV1 and SCOV2 in its COVIDITY phase I clinical trial. Read More →